GenMont Biotech Incorporation (TPE:3164)
17.75
-0.20 (-1.11%)
Apr 29, 2026, 1:30 PM CST
-7.79% (1Y)
| Market Cap | 1.53B |
| Revenue (ttm) | 401.23M |
| Net Income (ttm) | 57.20M |
| Shares Out | 86.01M |
| EPS (ttm) | 0.66 |
| PE Ratio | 26.89 |
| Forward PE | n/a |
| Dividend | 0.80 (4.46%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 41,812 |
| Average Volume | 50,395 |
| Open | 17.95 |
| Previous Close | 17.95 |
| Day's Range | 17.70 - 17.95 |
| 52-Week Range | 17.20 - 22.40 |
| Beta | 0.15 |
| RSI | 43.03 |
| Earnings Date | May 8, 2026 |